- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 54.5M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $34.41M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $48.39M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $18.43M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $23.43M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $27.28M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $32.78M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $154.59M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $173.66M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $225.39M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $242.79M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $3.61M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $4.96M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $29.63M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $210.01M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $216.04M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 57.1M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $824K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $6.5M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $7.57M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $4.35M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$8.26M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$10.93M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $7.14M |
| Revenue | Q1 2025 · Mar 31, 2024 | $12.09M |